Brazil's new rules on antibiotic prescriptions are good news for multinationals
This article was originally published in SRA
Executive Summary
A new resolution that has just come into force in Brazil means that patients will only be able to buy drugs containing antimicrobials with a controlled prescription1. Although the measure came largely in response to concerns over increasing resistance to antibiotics, it is also a positive move for multinationals because it means that if a doctor prescribes a brand, the pharmacist is more likely to actually dispense it.
You may also be interested in...
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.